CDC has released supplemental information for providers about the 9-valent HPV vaccine. The document summarizes some of the recommendations included in the original Policy Note and provides additional guidance for issues that were not addressed previously but are likely to arise during the transition from quadrivalent HPV vaccine to 9-valent HPV vaccine.
Supplemental Information and Guidance for Vaccination Providers Regarding Use of 9-valent HPV Vaccine
Jul 21, 2015 | Alyson Jordan
Related Posts
- Adverse Childhood Experiences (ACEs)
- Behavioral Health
- Community Health
- Injury and Violence Prevention
Seeking LHD Participants for an Intersectional Data...
With support from the Centers for Disease Control and Prevention, NACCHO is...
Mar 26, 2024 | Camille Adams
Seeking LHD Participants for an Intersectional Data...
- Mobilizing for Action through Planning and Partnerships (MAPP)
- Performance Improvement
- Workforce Development
Register to Attend a Mobilizing for Action through...
Registration is now open for NACCHO’s in-person Mobilizing for Action through...
Mar 23, 2024 | Andrea Grenadier